The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 17, 2020
Filed:
Jun. 02, 2017
Applicant:
Innopharmax, Inc., Taipei, TW;
Inventors:
Assignee:
INNOPHARMAX, INC., Taipei, TW;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/7068 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 47/26 (2006.01); A61K 9/48 (2006.01); A61K 47/10 (2017.01);
U.S. Cl.
CPC ...
A61K 31/7068 (2013.01); A61K 9/0053 (2013.01); A61K 9/107 (2013.01); A61K 9/48 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01);
Abstract
The disclosure relates to compositions and methods for treatment, such as inducing regression or inhibiting growth, of tumors in a patient such as a human. Use of gemcitabine, including in self-emulsifying orally administered dosage forms for these purposes is described. Gemcitabine is orally administered in a metronomic manner, which involves repeatedly administering a therapeutic amount of gemcitabine, being a fraction of the maximum tolerated dose, over an extended period of time, preferably on a non-interrupted schedule of weeks, months, or indefinitely.